This newsletter article discusses predicting a woman's age at menopause. It explains that predicting age at menopause can help women plan their families and target health interventions. While difficult, several markers can be used including estradiol, FSH, inhibin, and AMH levels. AMH in particular decreases steadily with age and can provide insights into ovarian reserve years before menopause. The article provides ranges for these markers in the reproductive, early transition, late transition, and post-menopausal stages. References are also included to support the discussion.
Tender Love and Care (TLC) in Recurrent Pregnancy Loss (RPL) Dr Sharda Jain D...Lifecare Centre
This document discusses tender love and care (TLC) in recurrent pregnancy loss (RPL). It defines RPL as three or more consecutive pregnancy losses. RPL can have psychological impacts like depression, anxiety, and stress on both women and their partners. Providing psychological support through TLC which includes frequent checkups, clear communication, emotional support, encouragement of positive coping strategies, and involvement of partners can help improve mental health and pregnancy outcomes for those experiencing RPL. Studies show TLC through a dedicated early pregnancy clinic or supportive partner behaviors significantly decreases miscarriage rates and increases live birth rates compared to no specific care or support.
This document provides guidance on cardiac disease and pregnancy. It notes that cardiac disease is a leading cause of maternal death in developed countries. The purpose is to summarize expert opinions to help plan management of affected pregnancies until more evidence is available. It discusses various types of cardiac conditions that pose risks in pregnancy such as myocardial infarction, peripartum cardiomyopathy, rheumatic heart disease, aortic dissection, and congenital heart disease. It provides recommendations on risk assessment, preconception counseling, antepartum care, intrapartum management, and postpartum care for women with cardiac conditions.
DHEA supplementation may improve ovarian reserve and fertility outcomes in women with diminished ovarian reserve (DOR). Studies show DHEA increases egg and embryo counts and quality, and pregnancy rates. It acts before, during or after the recruitment phase of follicle growth, preventing follicle atresia and increasing FSH receptors. DHEA supplementation in women over age 40 or those with elevated FSH or low ovarian reserve based on tests has shown benefits with few side effects at recommended doses of 25mg TID for at least 2 months prior to fertility treatment. Pregnancy loss rates were reduced by 50-80% with DHEA supplementation in studies.
1. Amenorrhea, or the absence of menstrual periods, can be either primary or secondary. Primary amenorrhea refers to the lack of menses by age 15, while secondary amenorrhea is the absence of periods for 3 months after menarche.
2. A thorough history and physical exam is important to evaluate the potential causes of amenorrhea, which can include pregnancy, eating disorders, medical conditions, or anatomical abnormalities.
3. Laboratory tests and imaging may be needed to diagnose endocrine disorders, such as hypothalamic, pituitary, ovarian, or thyroid issues, which can cause amenorrhea. Genetic testing may be considered if Turner syndrome is suspected.
DHEA supplementation can improve ovarian reserve and fertility outcomes in women with diminished ovarian reserve. It acts early in follicle development to stimulate growth and maturation. Studies show DHEA increases levels of AMH, the number of eggs and embryos retrieved in IVF, and pregnancy rates while decreasing cancellation rates. The optimal dosage is 25mg three times daily until pregnancy is achieved. DHEA is not recommended for PCOS patients unless they have low testosterone levels and are poor responders.
Pure DHEA Supplementation For Fertility TreatmentJason Peters
DHEA supplementation is a fertility treatment used mainly for women with diminished ovarian reserve. Studies by the Center for Human Reproduction in New York have found that pure DHEA increases egg and embryo quality and pregnancy rates. It can increase spontaneous conceptions and reduce miscarriages. Potential side effects include emotional changes, insomnia and headaches. Women with certain medical conditions should only take DHEA under a physician's supervision.
Unlocking I.V.F Services Redefining the New Normal Dr Sharda Jain Lifecare Centre
1) Frozen embryo transfer (FET) will likely be the treatment of choice after resumption of fertility practice due to its less invasive nature compared to fresh embryo transfer which involves ovarian stimulation.
2) FET cycles are associated with higher success rates than fresh embryo transfers in high responders who produce 15 or more eggs. They also carry lower risks of adverse outcomes like preterm birth and low birth weight.
3) To reduce stress experienced by ART patients during the pandemic, it is recommended to practice digital detox, meditation, interact with support groups, use self-help resources and maintain positive self-talk.
Tender Love and Care (TLC) in Recurrent Pregnancy Loss (RPL) Dr Sharda Jain D...Lifecare Centre
This document discusses tender love and care (TLC) in recurrent pregnancy loss (RPL). It defines RPL as three or more consecutive pregnancy losses. RPL can have psychological impacts like depression, anxiety, and stress on both women and their partners. Providing psychological support through TLC which includes frequent checkups, clear communication, emotional support, encouragement of positive coping strategies, and involvement of partners can help improve mental health and pregnancy outcomes for those experiencing RPL. Studies show TLC through a dedicated early pregnancy clinic or supportive partner behaviors significantly decreases miscarriage rates and increases live birth rates compared to no specific care or support.
This document provides guidance on cardiac disease and pregnancy. It notes that cardiac disease is a leading cause of maternal death in developed countries. The purpose is to summarize expert opinions to help plan management of affected pregnancies until more evidence is available. It discusses various types of cardiac conditions that pose risks in pregnancy such as myocardial infarction, peripartum cardiomyopathy, rheumatic heart disease, aortic dissection, and congenital heart disease. It provides recommendations on risk assessment, preconception counseling, antepartum care, intrapartum management, and postpartum care for women with cardiac conditions.
DHEA supplementation may improve ovarian reserve and fertility outcomes in women with diminished ovarian reserve (DOR). Studies show DHEA increases egg and embryo counts and quality, and pregnancy rates. It acts before, during or after the recruitment phase of follicle growth, preventing follicle atresia and increasing FSH receptors. DHEA supplementation in women over age 40 or those with elevated FSH or low ovarian reserve based on tests has shown benefits with few side effects at recommended doses of 25mg TID for at least 2 months prior to fertility treatment. Pregnancy loss rates were reduced by 50-80% with DHEA supplementation in studies.
1. Amenorrhea, or the absence of menstrual periods, can be either primary or secondary. Primary amenorrhea refers to the lack of menses by age 15, while secondary amenorrhea is the absence of periods for 3 months after menarche.
2. A thorough history and physical exam is important to evaluate the potential causes of amenorrhea, which can include pregnancy, eating disorders, medical conditions, or anatomical abnormalities.
3. Laboratory tests and imaging may be needed to diagnose endocrine disorders, such as hypothalamic, pituitary, ovarian, or thyroid issues, which can cause amenorrhea. Genetic testing may be considered if Turner syndrome is suspected.
DHEA supplementation can improve ovarian reserve and fertility outcomes in women with diminished ovarian reserve. It acts early in follicle development to stimulate growth and maturation. Studies show DHEA increases levels of AMH, the number of eggs and embryos retrieved in IVF, and pregnancy rates while decreasing cancellation rates. The optimal dosage is 25mg three times daily until pregnancy is achieved. DHEA is not recommended for PCOS patients unless they have low testosterone levels and are poor responders.
Pure DHEA Supplementation For Fertility TreatmentJason Peters
DHEA supplementation is a fertility treatment used mainly for women with diminished ovarian reserve. Studies by the Center for Human Reproduction in New York have found that pure DHEA increases egg and embryo quality and pregnancy rates. It can increase spontaneous conceptions and reduce miscarriages. Potential side effects include emotional changes, insomnia and headaches. Women with certain medical conditions should only take DHEA under a physician's supervision.
Unlocking I.V.F Services Redefining the New Normal Dr Sharda Jain Lifecare Centre
1) Frozen embryo transfer (FET) will likely be the treatment of choice after resumption of fertility practice due to its less invasive nature compared to fresh embryo transfer which involves ovarian stimulation.
2) FET cycles are associated with higher success rates than fresh embryo transfers in high responders who produce 15 or more eggs. They also carry lower risks of adverse outcomes like preterm birth and low birth weight.
3) To reduce stress experienced by ART patients during the pandemic, it is recommended to practice digital detox, meditation, interact with support groups, use self-help resources and maintain positive self-talk.
DHEA is a hormone that decreases with age and may improve fertility. Studies have found that DHEA supplements:
- Increase fertility rates by 300%
- Improve egg quality and rejuvenate ovaries
- Double IVF pregnancy rates, especially for women over 40
- Reduce miscarriage rates by 50-80%
DHEA appears to work by boosting FSH receptors, reducing cell death in ovaries, and improving embryo quality. It is being used successfully to treat infertility at centers worldwide.
Managing pregnancy in MS – an update (Since 2016)MS Trust
Dr Peter Brex presented an update on managing pregnancy in multiple sclerosis (MS). The key points were:
1) It is important to provide pre-pregnancy counseling to understand medication management during pregnancy and establish links with local obstetric teams.
2) While there are no clinical trials of disease-modifying therapies (DMTs) in pregnancy, data from pregnancy registries can provide guidance on safety.
3) Recommended time periods for stopping various DMTs prior to conception range from 5 months to over 2 years depending on the medication.
Fetal medicine is an upcoming branch of Obstetrics where the fetus is given the primary care right from screening to diagnosis and management of a fetal problem. Read more at http://bangalorefetalmedicine.com/
This document discusses the potential role of DHEA supplementation in improving oocyte yield and quality in women with diminished ovarian reserve or poor ovarian response. It provides biological plausibility for how DHEA may act on granulosa cells and follicles to reduce apoptosis and recruit more developmentally competent oocytes. The document reviews literature on DHEA's effects and side effects, and discusses questions that still need answers around its role as an adjuvant treatment in assisted reproductive technologies.
Obstetric outcomes associated with second trimester unexplained abnormal mate...Apollo Hospitals
1) To compare the adverse obstetrical outcomes in the patient population with normal blood MoMs.
2) To determine the probability of occurrence of an adverse obstetric event in relation with abnormal maternal blood
analytes.
This document defines premature ovarian failure as the loss of normal ovarian function before age 40, affecting 1% of women. It can be caused by genetic disorders, autoimmune diseases, chemotherapy/radiation, or unknown factors. Symptoms include irregular periods, hot flashes, and fertility issues. The condition is diagnosed through blood tests of follicle-stimulating hormone and estradiol levels. Treatment focuses on hormone replacement therapy and calcium/vitamin D supplements to prevent osteoporosis and relieve symptoms.
Clinical Experience on treating infertilityLIQIN ZHAO
This document summarizes the author's experience treating infertility using traditional Chinese medicine (TCM). It presents three case studies of patients who were treated with a combination of acupuncture, herbal medicine, and dietary changes. In the first case, a woman diagnosed with severe endometriosis conceived naturally after 11 weeks of TCM treatment. In the second case, a woman with polycystic ovarian syndrome (PCOS) and a history of miscarriages conceived naturally after four months of treatment. In the third case, a woman diagnosed with premature ovarian failure conceived after treatment to remove blood stasis and toxins from her body. The author found that TCM was effective at improving hormone levels, blood flow, and organ function
This document provides information about Dr. Laxmi Shrikhande's credentials and experience in gynecology and fertility. It then summarizes guidelines for assessing and managing polycystic ovary syndrome (PCOS) and infertility. Key recommendations include using letrozole as first-line pharmacological treatment for infertility in PCOS patients, and considering gonadotropins as second-line if letrozole fails. The risks of ovarian hyperstimulation syndrome are also discussed for PCOS patients undergoing fertility treatments like IVF.
This document summarizes the evolution of hormone therapy for menopause from 1942 to 2020. It discusses key studies that identified health risks associated with different types of hormone therapy. The Women's Health Initiative trials in the 1990s showed that combined estrogen-progestin therapy increases the risk of breast cancer and heart disease compared to estrogen-only therapy or placebo. Subsequent studies found that the progestin component and type of progestin are important factors in health risks. Ongoing research continues to evaluate the appropriate uses and timing of hormone therapy to maximize benefits and minimize risks.
This document discusses the potential use of DHEA as a supplement for women who are poor responders to IVF treatment. It provides background on DHEA, reviews several studies that have investigated its effects, and shares the author's experience. While some studies found benefits like increased oocyte yield and pregnancy rates, the evidence is still inconclusive. The author's own retrospective analysis found no significant differences in outcomes between DHEA users and non-users. They conclude that more randomized controlled trials are still needed before DHEA can be routinely recommended to improve IVF success rates for poor responders.
Já acompanhamos alguns casos, mas há poucos publicações nessa área. A Lactação Adotiva é um fenômeno bem descrito e logramos sucesso em muitos casos.
Comprometo-me a reunir mais estudos sobre esses temas.
IOSR Journal of Pharmacy and Biological Sciences(IOSR-JPBS) is an open access international journal that provides rapid publication (within a month) of articles in all areas of Pharmacy and Biological Science. The journal welcomes publications of high quality papers on theoretical developments and practical applications in Pharmacy and Biological Science. Original research papers, state-of-the-art reviews, and high quality technical notes are invited for publications.
The method of ovulation induction selected by the clinician should be based upon the underlying cause of anovulation and the efficacy, costs, risks, burden of treatment, and potential complications associated with each method as they apply to the individual woman. In this presentation I have mentioned every points in detail.
Senturk, lm emas webinar infertility and hyperandrogenism_20181205TrkiyeMenopozVeOsteo
This document summarizes fertility problems in women with androgen excess. It discusses various causes of hyperandrogenism including polycystic ovary syndrome (PCOS), which accounts for 80% of cases. It then outlines treatment approaches including lifestyle management, pharmacological options, and assisted reproductive technologies. First line pharmacological treatments include combined oral contraceptives, anti-androgens, and metformin. Second line options include gonadotropins and laparoscopic ovarian drilling.
This document discusses sexuality issues related to breast cancer and provides answers. It begins with disclosures from the author about consulting and speaking for pharmaceutical companies. It then discusses how oncology care has expanded to include sexual medicine and focusing on the patient. Studies show low rates of sexuality discussions between patients and healthcare providers before or after breast cancer treatment. The types of female sexual dysfunction are defined according to diagnostic criteria. Estimates of the prevalence of various sexual complaints after breast cancer, such as desire disorders, arousal and lubrication concerns, and dyspareunia, range from 16-100% according to different studies. Factors that can impact sexual function in breast cancer survivors are discussed, including lifestyle factors, mindfulness-based approaches, and hormone
Polycystic Ovarian Syndrome Diagnosis in a Patient Undergoing Treatment for B...Premier Publishers
BACKGROUND: The association between bipolar affective disorder (BAD) and polycystic ovarian syndrome (PCOS) is elucidated in medical literature. However, what is inconclusive is whether one causes the other and /or the neuroleptics such as sodium valproate could cause PCOS as a side effect. However, to the best of our knowledge, there is a dearth of such case reports in our setting. We therefore report a case of this nature in our setting with the aim of further reemphasizing the likely comorbidity and the need for collaborative multidisciplinary approach during management of such patients. CASE REPORT: We present a case of 34 years old, parity 0+1, human immune virus seronegative, a known patient of bipolar affective disorder (BAD) for 18 years. She was initially started on chlorpromazine and carbamazepine that she used for 13 years and later switched to sodium valproate and sertraline daily due to side effects of chlorpromazine in 2014. She presented with 6 years history of abnormal uterine bleeding and dysmennorrhoea for 2 months. A diagnosis of PCOS was made based on history and confirmed by laboratory and radiological investigations. CONCLUSIONS: Physicians need be aware of the likely comorbidity or sequel and the need for multidisciplinary engagement.
The document summarizes a study that analyzed the association between allelic combinations of two polymorphisms in the FSH receptor (FSHR) gene and ovarian response in women undergoing in vitro fertilization (IVF). The polymorphisms located at positions -29 and 680 of the FSHR gene were genotyped. The combinations of these polymorphisms formed nine discrete genotypes. Clinical data from 150 IVF subjects was analyzed based on genotype. Results showed that 75% of subjects with the A/A–Asn/Asn genotype were poor ovarian responders, with an odds ratio of 7.92. This genotype also had significantly lower FSHR mRNA expression in granulosa cells compared to other genotypes. The study
Menopausal hormone therapy (MHT) also called postmenopausal hormone therapy and hormone replacement therapy. Here is presentation on Menopausal hormone therapy by Dr. Laxmi Shrikhande
Optimization of ovarian stimulation to improve success rate in ‘ART’Apollo Hospitals
ART is defined as the technique used where there is a need for in-vitro preparation or manipulation of gametes. The commonest ARTs are intrauterine insemination (IUI) and in-vitro fertilization (IVF). Ovarian stimulation is required with these procedures to increase the pregnancy rate as ART with natural cycle has a very low pregnancy rate. Optimizing pregnancy rates per cycle is the real basis for ovarian stimulation protocols in ART.
Oration delivered by Dr Sujoy Dasgupta at Yuvacon, conference organized by the BOGS (Bengal Obstetric and Gynaecological Society) held on 22-23 April, 2023
Are we giving much importance to AMH in infertility practice?Sujoy Dasgupta
Dr Sujoy Dasgupta delivered "Kamini Rao Oration" on "Are we giving much importance to AMH in infertility practice?" in East Zone Yuva FOGSI Conference organized by Imphal Obstetric and Gynaecological Society (IOGS) on 24 December, 2023
DHEA is a hormone that decreases with age and may improve fertility. Studies have found that DHEA supplements:
- Increase fertility rates by 300%
- Improve egg quality and rejuvenate ovaries
- Double IVF pregnancy rates, especially for women over 40
- Reduce miscarriage rates by 50-80%
DHEA appears to work by boosting FSH receptors, reducing cell death in ovaries, and improving embryo quality. It is being used successfully to treat infertility at centers worldwide.
Managing pregnancy in MS – an update (Since 2016)MS Trust
Dr Peter Brex presented an update on managing pregnancy in multiple sclerosis (MS). The key points were:
1) It is important to provide pre-pregnancy counseling to understand medication management during pregnancy and establish links with local obstetric teams.
2) While there are no clinical trials of disease-modifying therapies (DMTs) in pregnancy, data from pregnancy registries can provide guidance on safety.
3) Recommended time periods for stopping various DMTs prior to conception range from 5 months to over 2 years depending on the medication.
Fetal medicine is an upcoming branch of Obstetrics where the fetus is given the primary care right from screening to diagnosis and management of a fetal problem. Read more at http://bangalorefetalmedicine.com/
This document discusses the potential role of DHEA supplementation in improving oocyte yield and quality in women with diminished ovarian reserve or poor ovarian response. It provides biological plausibility for how DHEA may act on granulosa cells and follicles to reduce apoptosis and recruit more developmentally competent oocytes. The document reviews literature on DHEA's effects and side effects, and discusses questions that still need answers around its role as an adjuvant treatment in assisted reproductive technologies.
Obstetric outcomes associated with second trimester unexplained abnormal mate...Apollo Hospitals
1) To compare the adverse obstetrical outcomes in the patient population with normal blood MoMs.
2) To determine the probability of occurrence of an adverse obstetric event in relation with abnormal maternal blood
analytes.
This document defines premature ovarian failure as the loss of normal ovarian function before age 40, affecting 1% of women. It can be caused by genetic disorders, autoimmune diseases, chemotherapy/radiation, or unknown factors. Symptoms include irregular periods, hot flashes, and fertility issues. The condition is diagnosed through blood tests of follicle-stimulating hormone and estradiol levels. Treatment focuses on hormone replacement therapy and calcium/vitamin D supplements to prevent osteoporosis and relieve symptoms.
Clinical Experience on treating infertilityLIQIN ZHAO
This document summarizes the author's experience treating infertility using traditional Chinese medicine (TCM). It presents three case studies of patients who were treated with a combination of acupuncture, herbal medicine, and dietary changes. In the first case, a woman diagnosed with severe endometriosis conceived naturally after 11 weeks of TCM treatment. In the second case, a woman with polycystic ovarian syndrome (PCOS) and a history of miscarriages conceived naturally after four months of treatment. In the third case, a woman diagnosed with premature ovarian failure conceived after treatment to remove blood stasis and toxins from her body. The author found that TCM was effective at improving hormone levels, blood flow, and organ function
This document provides information about Dr. Laxmi Shrikhande's credentials and experience in gynecology and fertility. It then summarizes guidelines for assessing and managing polycystic ovary syndrome (PCOS) and infertility. Key recommendations include using letrozole as first-line pharmacological treatment for infertility in PCOS patients, and considering gonadotropins as second-line if letrozole fails. The risks of ovarian hyperstimulation syndrome are also discussed for PCOS patients undergoing fertility treatments like IVF.
This document summarizes the evolution of hormone therapy for menopause from 1942 to 2020. It discusses key studies that identified health risks associated with different types of hormone therapy. The Women's Health Initiative trials in the 1990s showed that combined estrogen-progestin therapy increases the risk of breast cancer and heart disease compared to estrogen-only therapy or placebo. Subsequent studies found that the progestin component and type of progestin are important factors in health risks. Ongoing research continues to evaluate the appropriate uses and timing of hormone therapy to maximize benefits and minimize risks.
This document discusses the potential use of DHEA as a supplement for women who are poor responders to IVF treatment. It provides background on DHEA, reviews several studies that have investigated its effects, and shares the author's experience. While some studies found benefits like increased oocyte yield and pregnancy rates, the evidence is still inconclusive. The author's own retrospective analysis found no significant differences in outcomes between DHEA users and non-users. They conclude that more randomized controlled trials are still needed before DHEA can be routinely recommended to improve IVF success rates for poor responders.
Já acompanhamos alguns casos, mas há poucos publicações nessa área. A Lactação Adotiva é um fenômeno bem descrito e logramos sucesso em muitos casos.
Comprometo-me a reunir mais estudos sobre esses temas.
IOSR Journal of Pharmacy and Biological Sciences(IOSR-JPBS) is an open access international journal that provides rapid publication (within a month) of articles in all areas of Pharmacy and Biological Science. The journal welcomes publications of high quality papers on theoretical developments and practical applications in Pharmacy and Biological Science. Original research papers, state-of-the-art reviews, and high quality technical notes are invited for publications.
The method of ovulation induction selected by the clinician should be based upon the underlying cause of anovulation and the efficacy, costs, risks, burden of treatment, and potential complications associated with each method as they apply to the individual woman. In this presentation I have mentioned every points in detail.
Senturk, lm emas webinar infertility and hyperandrogenism_20181205TrkiyeMenopozVeOsteo
This document summarizes fertility problems in women with androgen excess. It discusses various causes of hyperandrogenism including polycystic ovary syndrome (PCOS), which accounts for 80% of cases. It then outlines treatment approaches including lifestyle management, pharmacological options, and assisted reproductive technologies. First line pharmacological treatments include combined oral contraceptives, anti-androgens, and metformin. Second line options include gonadotropins and laparoscopic ovarian drilling.
This document discusses sexuality issues related to breast cancer and provides answers. It begins with disclosures from the author about consulting and speaking for pharmaceutical companies. It then discusses how oncology care has expanded to include sexual medicine and focusing on the patient. Studies show low rates of sexuality discussions between patients and healthcare providers before or after breast cancer treatment. The types of female sexual dysfunction are defined according to diagnostic criteria. Estimates of the prevalence of various sexual complaints after breast cancer, such as desire disorders, arousal and lubrication concerns, and dyspareunia, range from 16-100% according to different studies. Factors that can impact sexual function in breast cancer survivors are discussed, including lifestyle factors, mindfulness-based approaches, and hormone
Polycystic Ovarian Syndrome Diagnosis in a Patient Undergoing Treatment for B...Premier Publishers
BACKGROUND: The association between bipolar affective disorder (BAD) and polycystic ovarian syndrome (PCOS) is elucidated in medical literature. However, what is inconclusive is whether one causes the other and /or the neuroleptics such as sodium valproate could cause PCOS as a side effect. However, to the best of our knowledge, there is a dearth of such case reports in our setting. We therefore report a case of this nature in our setting with the aim of further reemphasizing the likely comorbidity and the need for collaborative multidisciplinary approach during management of such patients. CASE REPORT: We present a case of 34 years old, parity 0+1, human immune virus seronegative, a known patient of bipolar affective disorder (BAD) for 18 years. She was initially started on chlorpromazine and carbamazepine that she used for 13 years and later switched to sodium valproate and sertraline daily due to side effects of chlorpromazine in 2014. She presented with 6 years history of abnormal uterine bleeding and dysmennorrhoea for 2 months. A diagnosis of PCOS was made based on history and confirmed by laboratory and radiological investigations. CONCLUSIONS: Physicians need be aware of the likely comorbidity or sequel and the need for multidisciplinary engagement.
The document summarizes a study that analyzed the association between allelic combinations of two polymorphisms in the FSH receptor (FSHR) gene and ovarian response in women undergoing in vitro fertilization (IVF). The polymorphisms located at positions -29 and 680 of the FSHR gene were genotyped. The combinations of these polymorphisms formed nine discrete genotypes. Clinical data from 150 IVF subjects was analyzed based on genotype. Results showed that 75% of subjects with the A/A–Asn/Asn genotype were poor ovarian responders, with an odds ratio of 7.92. This genotype also had significantly lower FSHR mRNA expression in granulosa cells compared to other genotypes. The study
Menopausal hormone therapy (MHT) also called postmenopausal hormone therapy and hormone replacement therapy. Here is presentation on Menopausal hormone therapy by Dr. Laxmi Shrikhande
Optimization of ovarian stimulation to improve success rate in ‘ART’Apollo Hospitals
ART is defined as the technique used where there is a need for in-vitro preparation or manipulation of gametes. The commonest ARTs are intrauterine insemination (IUI) and in-vitro fertilization (IVF). Ovarian stimulation is required with these procedures to increase the pregnancy rate as ART with natural cycle has a very low pregnancy rate. Optimizing pregnancy rates per cycle is the real basis for ovarian stimulation protocols in ART.
Oration delivered by Dr Sujoy Dasgupta at Yuvacon, conference organized by the BOGS (Bengal Obstetric and Gynaecological Society) held on 22-23 April, 2023
Are we giving much importance to AMH in infertility practice?Sujoy Dasgupta
Dr Sujoy Dasgupta delivered "Kamini Rao Oration" on "Are we giving much importance to AMH in infertility practice?" in East Zone Yuva FOGSI Conference organized by Imphal Obstetric and Gynaecological Society (IOGS) on 24 December, 2023
JR Evaluation of Female Fertility—AMH and Ovarian.pptxAsriIndriyaniPutri
This document summarizes a journal reading on the evaluation of female fertility using antimüllerian hormone (AMH) and ovarian reserve testing. It discusses how AMH levels can help characterize menstrual cycles, diagnose conditions like polycystic ovary syndrome, predict ovarian response to fertility treatments, and provide counseling on expected outcomes. The document includes figures and discusses strategies for diagnosing and managing infertility using AMH testing and other clinical markers of ovarian reserve.
Is miscarriage preventable? gynae symposiumobsgynhsnz
This document discusses the prevention of miscarriage and use of progesterone in early pregnancy. It begins by noting that 1 in 3 pregnant women experience bleeding in the first trimester, which is often the first sign of a possible miscarriage. It then examines the evidence on various potential preventative measures, finding little evidence that bed rest is effective and no significant differences in outcomes for vitamin supplementation. While uterine muscle relaxants and hCG have also not been shown to reduce miscarriage risk, progesterone supplementation is discussed as an option, given indirect evidence of its role in maintaining early pregnancy. The document evaluates this option in the context of the patient case presented.
Recent Trends in Pubertal Timing and Current Management of Precocious Puberty...Apollo Hospitals
Precocious puberty is defined as the development of pubertal signs at a younger age than the accepted lower limits for the onset of puberty. In girls, breast development before the age of 8 years, appearance of sexual pubic hair before the age of 8 years or beginning menses before the age of 9.5 years is traditionally considered as precocious puberty. This is accompanied by rapid growth rate, advanced skeletal maturation and increased levels of gonadotropins and/or sex steroids.
This document discusses issues related to women with epilepsy, including:
- About half of women with epilepsy are of reproductive age. Enzyme-inducing antiepileptic drugs can reduce the effectiveness of contraceptives.
- Catamenial epilepsy involves seizures related to the menstrual cycle. Hormonal treatments like progesterone can help control seizures.
- Epilepsy during pregnancy presents challenges of balancing seizure control and risks of medication. Risks include fetal malformations, developmental effects, and pregnancy complications. Lower-risk drugs include lamotrigine and levetiracetam. Frequent monitoring is important.
- Pregnancy can impact epilepsy through hormonal changes and drug level fluctuations requiring dose adjustments
This document discusses the use of letrozole for ovulation induction. It begins by explaining how letrozole works at a molecular level to stimulate follicular growth, noting key differences from clomiphene citrate such as not blocking estrogen receptors and maintaining feedback inhibition. Clinical studies are then summarized finding letrozole to have higher ovulation and live birth rates than clomiphene citrate, especially in women with PCOS or who are clomiphene citrate resistant. The document concludes by stating letrozole has been used successfully for ovulation induction in PCOS, intrauterine insemination, and ovarian stimulation for IVF/ICSI.
This document discusses menopause and hormone replacement therapy. It begins by defining menopause as the permanent stoppage of menstruation due to declining ovarian function. It then discusses the stages of menopause including perimenopause and the changes in hormones like FSH and estrogen that occur. The document notes that menopause is a natural process but can cause both short term symptoms and long term health issues if estrogen is not replaced. It evaluates the risks and benefits of different treatment options for menopause including lifestyle changes, alternative therapies, medical treatments, and hormone replacement therapy.
This document discusses the use of letrozole for fertility treatments. It begins with an introduction and outline on polycystic ovary syndrome (PCOS), unexplained infertility, fertility preservation for breast cancer patients, frozen embryo transfer, and decreasing ovarian hyperstimulation syndrome (OHSS). It then goes into more detail on each topic, providing evidence from randomized controlled trials, meta-analyses, and clinical guidelines that letrozole results in higher pregnancy and live birth rates compared to clomiphene citrate for PCOS and unexplained infertility. It also discusses how letrozole can be used during fertility preservation for breast cancer patients to prevent high estrogen levels. The document concludes by stating letrozole may
A 15-year-old female presented to the emergency department with vaginal bleeding and weakness. She was found to have a hemoglobin of 2.4g/dL and pelvic examination revealed spontaneous discharge of blood, clots and grapelike spongy material. Surgical pathology confirmed a complete hydatidiform mole (molar pregnancy). She received blood transfusions and was taken urgently to the operating room for dilation and curettage. Molar pregnancies can present with vaginal bleeding and excessive beta-human chorionic gonadotropin levels, as seen in this case.
OVARIAN RESERVE DIAGNOSIS & MANAGEMENT DR Sharda Jain Lifecare Centre
Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of remaining eggs. It can be caused by factors like advanced age, chemotherapy, genetics, and lifestyle. Ovarian reserve tests assess markers like antral follicle count, anti-Mullerian hormone, and follicle-stimulating hormone to predict ovarian response. A combination of biochemical tests is effective for predicting diminished ovarian reserve. When test results indicate poor ovarian reserve, treatment options include protocols using gonadotropins, letrozole, or dehydroepiandrosterone to potentially increase live birth rates from in vitro fertilization.
Explore the intricacies of ovulation induction in intrauterine insemination (IUI) with Dr Laxmi Shrikhande's informative slide share presentation. From understanding the hormonal mechanisms to the latest techniques, this presentation offers insights into optimizing fertility through IUI. Whether you're a clinician seeking to enhance patient outcomes or an individual navigating fertility treatments, this resource provides valuable knowledge for your journey towards conception.
Poor and hyper responders: biomarkers management, strategies
This document discusses the use of biomarkers such as AMH, AFC, and genetic markers to predict ovarian response and tailor IVF stimulation strategies. Key points:
1. AMH and AFC are effective at predicting poor and hyper ovarian response but not live birth rates. They are useful for choosing protocols.
2. Genetic markers of FSH and LH receptors can help explain hypo-sensitivity to FSH in some patients.
3. An integrated approach combining hormonal, functional and genetic biomarkers is needed to select the optimal treatment protocol for each patient.
4. Individualized treatment based on biomarkers can reduce cancellations, OHSS
Poor and hyper responders: biomarkers management, strategies
This document discusses the use of biomarkers such as AMH, AFC, and genetic markers to predict ovarian response and tailor IVF stimulation strategies. Key points:
1. AMH and AFC are effective at predicting poor and hyper ovarian response but not sufficient for live birth counseling.
2. Biomarkers can help choose protocols, such as using GnRH antagonists for normal responders and agonists to avoid OHSS in high responders.
3. An integrated approach considering hormonal, functional, and genetic biomarkers is needed to determine the optimal treatment strategy for each patient. FSH dose and potential LH supplementation should account for genetic
Central and Peripheral Precocious PubertyUsama Ragab
Precocious Puberty
By Dr. Usama Ragab Youssif
Precocious puberty (PP) is defined as the development of pubertal changes (2ry sexual characters), at an age younger than the accepted lower limits for age of onset of puberty.
1. The document discusses threatened and unexplained recurrent miscarriages. It provides information on the definition, incidence, types, causes, prognosis, and management of threatened and recurrent miscarriages.
2. For threatened miscarriages, the use of progestins is the most promising treatment and can significantly reduce the rate of miscarriage compared to placebo. For unexplained recurrent miscarriages, the prognosis is generally good without intervention, as many cases are due to chromosomal abnormalities rather than underlying maternal issues.
3. Basic investigations should be performed to investigate potential causes of recurrent miscarriage such as anatomical abnormalities, endocrine disorders, infections, thrombophilias, and alloimmune factors. However, for most cases
The document provides information about an Audiology Brainstem Response (ABR) test. It describes what an ABR test measures (electrical activity in the auditory nerve and brainstem in response to sounds), its main clinical uses (identifying neurological abnormalities in the auditory nerve/pathways and estimating hearing sensitivity), and the typical waveform characteristics. It also outlines two main patient groups that benefit from ABR testing - those with suspected neural problems and those who can't complete a standard hearing test.
1) A 1 year 7 month old boy was admitted with diarrhea and vomiting for 2 days and fever for 1 day. Stool culture revealed moderate growth of Vibrio cholerae.
2) Cholera is uncommon in children under 2 years old but can occur. Early detection is important to prevent outbreaks.
3) The case is presented to raise public awareness of the possibility of cholera in young children and of its potential to cause large outbreaks if not contained.
This document discusses Extended Spectrum Beta Lactamase (ESBL) producing Escherichia coli infections in urine. It begins by providing background information on gram negative bacilli and beta lactamase structure. It then continues to discuss the importance of screening and treatment for these types of drug-resistant E. coli infections in urine.
This document discusses Extended Spectrum Beta Lactamase (ESBL) producing Escherichia coli infections in urine. It begins by providing background information on gram negative bacilli and beta lactamase structure. It then continues to discuss the importance of screening and treatment for these types of drug-resistant E. coli infections in urine.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
The Nervous and Chemical Regulation of Respiration
Parami News Letter -December-2011
1. NEWSLETTER
Issue 5 December, 2011
Holistic, Compassionate and Quality Healthcare
Advisory Group Predicting Age at Menopause
Prof. U Thein Aung
Dr. Nyein Moe Thaw
Prof. U Khin Maung Aye
M.B.,B.S, M.Med.Sc (OG), Dr. Med.Sc (OG)
Dr. Tin Nyunt
Prof. U Saw Win
P redicting age at menopause and ovarian reserve is of great interest in women who
wish to delay childbearing and who wish to know their ovarian reserve. Age at menopause may
Prof. Daw Mya Thidar also be of relevance because many health conditions are linked to age at menopause. Lower
Prof. U Ne Win age at menopause is linked to an increased risk for cardiovascular disease and osteoporosis.
Older age at menopause is linked to an increased risk for breast cancer, endometrial cancer,
Editorial Board
and possibly ovarian cancer. So, women may be able to target certain interventions for
Dr. Myint Lwin
reducing risk earlier in life if they have this information about when they are likely to go
Dr. Shwe Baw
through menopause.
Dr. Zay Ya Aye A valid prediction of the time to menopause is still a challenge for a practising
Dr. Tin Moe Phyu physician. Ovarian aging is dictated by decreasing quantity and quality of the resting follicles
Dr. Khin Than Htay and depletion in the oocyte stock, after which menopause occurs. Because it is not feasible
Dr. Thidar Oo to directly assess the oocyte or follicle pool, endocrinologic and sonographic markers are
used as an indirect measure. A woman’s fertility ends ten years prior to the final menstrual
Dr. Nyein Moe Thaw
period (FMP) and can even occur around the age of thirty. With regard to family planning
Dr. Hnin Thuzar Aung
and a career, it is extremely valuable for women to know the expected length of their fertility.
Contact Us This knowledge will enable women who are predicted to become infertile at an early age to
No-60, G-1, choose the option of having their eggs frozen. This means that they will still be able to have
New Parami Road, children if it turns out that they can no longer get pregnant spontaneously.
Mayangone Tsp,
Prediction of age at menopause can be enhanced by using markers of ovarian reserve;
Yangon, Myanmar.
estradiol, follicular stimulating hormone (FSH), inhibin , and antimüllerian hormone (AMH).
Tel : 651674, 660083,
While one cannot use a single test to determine time to FMP, the menstrual cycle pattern and
657228 to 657232
hormonal characteristics can be used to generate rough estimates for counseling patients.
info@paramihospital.
The reproductive stage is generally characterized by regular menstrual cycles, early
Free Distribution follicular phase FSH levels less than 10 mIU/mL, and AMH levels greater than 0.3 ng/mL.
The contents of the The early menopausal transition begins approximately 7 to 8 years prior to the FMP. FSH
newsletter are not to be values are generally greater than 10 mIU/mL, and AMH levels are less than 0.4 ng/mL in
reproduced in any form this group of women.1,2 The late menopausal transition begins approximately 3 to 4 years
without prior written prior to the FMP. Occurrence of the late menopausal transition stage is confirmed when
approval of the
early follicular phase estradiol levels are greater than 100 pg/mL or FSH values are greater
editorial board.
(To Page - 2 _____)
>
2. Issue - 5, December 2011 Page - 2 Parami Hospital - Yangon, Newsletter
Continued from Predicting Age At Menopause (Page - 1) Picture Quiz
Dr. Tin Moe Phyu
than 30 to 40 mIU/mL.1,3 AMH values are generally less M.B.,B.S, MMedSc ( Paediatrics ), MRCPCH (UK),
4 Assistant Lecturer, Department of Paediatrics,
than 0.1 ng/mL (or below assay sensitivity). While the
term Menopause appears easy to define as “12 months of Yangon Children Hospital, University of Medicine ( 1 ) Yangon
amenorrhoea,” differentiating women in the late menopausal
transition from those in early postmenopause can be difficult
A n eight years old boy, body weight 21 kg,
came to Parami Hospital-Yangon OPD with the complaint
within the first 12 months following the FMP.
of gradual increase in weakness of lower limbs since 3
Among these various markers, serum AMH has years ago. He also had history of frequently falls during
several unique characteristics that emphasize its robustness playing. He was previously well and there was no history
as a biologic marker of ovarian aging. AMH is secreted of hospitalization. Birth history (Including both antenatal
exclusively in ovarian follicles and is independent of the and natal history) was uneventful.
menstrual cycle; its level remains almost constant from one There was no similar problem among family
cycle to another. 5 AMH seems to regulate the early follicular members . His developmental milestones are normal. He
development,6 and its serum concentration decreases with started to walk at about 1 year and 3 months. He is currently
attending 4th standard and he is doing well in school lessons
advancing age before changes in other markers such as
and examinations. Immunization history was said to be
follicular-stimulating hormone and inhibin B become
complete.
apparent.7,8
On examination, currently he is well, alert and
References
f happy. He does not have any dysmorphic feature. However,
1. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the
his legs are big compared to his upper limbs. The following
menopausal transition: a crosssectional study of a population-based sample.
pictures showed his funny big legs and his activities in trying
J Clin Endocrinol Metab. 1995;80 (12):3537-3545.
2. Gracia CR, Sammel MD, Freeman EW, et al. Defining menopause status: to stand up from lying position.
creation of a new definition to identify the early changes of the menopausal
transition. Menopause. 2005;12(2):128-135.
3. Santoro N, Brockwell S, Johnston J, et al. Helping midlife women predict
the onset of the final menses: SWAN, the Study of Women’s Health Across
the Nation. Menopause. 2007;14(3 pt 1):415-424.
4. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-mullerian hormone
and inhibin B in the definition of ovarian aging and the menopause transition.
J Clin Endocrinol Metab. 2008;93(9):3478- 3483.
5. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER,
Broekmans FJ. Antimüllerian hormone levels in the spontaneous menstrual
cycle do not show substantial fluctuation. J Clin Endocrinol Metab
2006;91:4057–4063.
6. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the
role of antimüllerian hormone. Reproduction 2002; 124:601–609.
7. Van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimüllerian hormone
levels best reflect the reproductive decline with age in normal women with
proven fertility: a longitudinal study. Fertil Steril 2005;83:979–987.
l
8. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian
hormone serum levels: a putative marker for ovarian aging. Fertil Steril
2002;77:357–362. (To Page - 3 _____)
>
3. Issue - 5, December 2011 Page - 3 Parami Hospital - Yangon, Newsletter
Continued from Picture Quiz Leisure Reading
(Page -2)
Control of You r
Your
Respiratory system, cardiovas- Heart
cular system and locomotor system
examinations are normal. His A wise and understanding
heart does not repay a hurt with a hurt.
neurological examination is normal
In doing so, the heart is diminished.
apart from slight decrease in tone of
Fissures form. Love leaks out. Every
both lower limbs and difficulty to stand
pain given in return for one received,
up from sitting and lying position.
changes the contents of the heart. It
All laboratory investigations is no longer defined by love, wisdom
( CP, U&E, Calcium ) are within normal and understanding. It is redefined by
range. However, serum creatine kinase the bearers of hurt and hate, pain and
( CK ) is 15632 IU/L ( normal <160 prejudice, meanness and madness,
IU/L ). Chest X-ray and ECG are sorrow and sadness. You give away
normal. control of your very own heart.
The despair of being hurt is
healed by overcoming it, not clinging
Q
Question
to the hurt and inflicting more of it on
1. What is the abnormality of his the world. When darkness is added to
legs? darkness, no one can see, no one can
2. What is the important physical love. Everyone loses.
sign shown in the photograph ? Love is not always warm and
fuzzy. Sometimes it’s the integrity we
Answers To Page ( 4 )
hold on to when we’re tempted to strike
back. Sometimes it’s the honour that
keeps us from exchanging the valuable
contents of our heart for the harsh
satisfaction of lashing back.
No, the way of love is not
always easy, but when night falls, dawn
is assured. The integrity and honour of
a wise and understanding heart, rises
with the sun of a new day.
( Ref : Morning Reading Classics )
4. Issue - 5, December 2011 Page - 4 Parami Hospital - Yangon, Newsletter
.... to our Beloved Customers …. Picture Quiz Answers
Answer
If special healthcare
1. Calves pseudohypertrophy
Is what you desire,
2. Gower sign
Ready to help you —
3. Duchenne muscular dystrophy ( D/Dx Becker
Is our team '' Parami! " .
muscular dystrophy).
Should consultation by appointment,
Duchenne muscular dystrophy is the most common
Is what you seek, hereditary neuromuscular disease . Its characteristic clinical
Just give us a call features are progressive weakness, intellectual impairment,
And express your needs —
d hypertrophy of the calves, and proliferation of connective
Your choice of doctors,
r tissue in muscle. The incidence is 1 : 3,600 liveborn infant
Your choice of time ………. boys. This disease is inherited as an X-linked recessive trait.
The abnormal gene is at the Xp21 locus. Becker muscular
to receive our healthcare :
dystrophy is the same fundamental disease as Duchenne
well-specialized and highly standardized!
dystrophy, with a genetic defect at the same locus, but
For our most valued customers, clinically it follows a milder and more protracted course.
Our team “Parami” The serum CK level is consistently greatly elevated,
Will create an atmosphere even in presymptomatic stages, including at birth.
Always warm and friendly Cardiomyopathy and respiratory muscle weakness are
And fulfill your needs readily complications of disease progress. Echocardiography,
electrocardiography (ECG), and radiography of the
To make you feel at ease
chest are essential and should be repeated periodically.
And clear you of your disease
Electromyography (EMG) shows characteristic myopathic
in next to no time, indeed!
features. Blood polymerase chain reaction (PCR) for the
dystrophic gene mutation and muscle biopsy are diagnostic
Dr. Khin Than Htay tests.
There is no specific treatment. Multidisplinary
team approach including physiology is an essential part
of management. Oral prednisolone therapy may have
improvement in short term and long term prognosis.
Because of progressive muscle weakness, some
patients become wheelchair users around 7 years of age.
Death occurs usually at about 18–20 years of age. The causes
of death are respiratory failure in sleep, intractable heart
failure, pneumonia, or occasionally aspiration and airway
obstruction.
Oralon Mouth Rinse Minolac 10 mg Tablet
(Chlorhexidine Gluconate Solution 1.0%) (Ketorolac Tromethamine)
Wincetam Syrup, 400 mg Capsule and 800 mg Caplet Lefora 10 mg and 20 mg Tablet
(Piracetam) (Leflunomide)
This Newsletter is supported by Network Marketing LTD.